Insulin pumps—more formally known as continuous subcutaneous insulin infusion, or CSII—help maintain tight glycemic control, ultimately preventing or delaying complications of diabetes. In this program, a panel of expert faculty and pump-using patients with type 1 diabetes share their expertise and experience. They provide practical guidance on patient selection criteria, concomitant use of continuous glucose monitoring, avoiding hypoglycemia, troubleshooting, and counseling that helps patients successfully incorporate CSII into their diabetes management.
Endocrinologists, diabetologists, and certified diabetes educators
At the conclusion of this educational activity, participants should be able to:
- Recognize the benefits and risks of continuous subcutaneous insulin infusion (CSII) therapy and counsel patients and caregivers accordingly
- Select patients for CSII therapy to ensure greater success with insulin infusion therapy (“readiness factors”) and provide ongoing patient education and support from the healthcare team
- Assess the varied options for continuous infusion therapy for T1DM patients and the need for continuous glucose monitoring to ensure optimal glycemic control
- Devise practical strategies that engage and reinforce patients in diabetes self‐management, including the use of coaches, social media, and telecommunications technology
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship of Albert Einstein College of Medicine of Yeshiva University and Haymarket Medical Education. Albert Einstein College of Medicine of Yeshiva University is accredited by the ACCME to provide continuing medical education for physicians.
Albert Einstein College of Medicine of Yeshiva University designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Bruce W. Bode, MD, FACE (CHAIR)
President, Atlanta Diabetes Associates
Clinical Associate Professor of Medicine
H. Peter Chase, MD
Professor of Pediatrics
Barbara Davis Center for Childhood Diabetes
University of Colorado School of Medicine
Steven V. Edelman, MD
Clinical Professor of Medicine
University of California, San Diego School of Medicine
Founder, Taking Control of Your Diabetes
San Diego, CA
Howard Wolpert, MD
Director, Insulin Pump Program
Joslin Diabetes Center
CME COURSE ADVISOR
Joel Zonszein, MD
Professor of Clinical Medicine (Medicine/Endocrinology)
Albert Einstein College of Medicine of Yeshiva University
Conflict of Interest
The Conflict of Interest Disclosure Policy of Albert Einstein College of Medicine of Yeshiva University requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.
Bruce W. Bode, MD, FACE, is on the speakers’ bureaus of Insulet Corporation and Medtronic, Inc., and is a consultant for Medtronic, Inc., Tandem Diabetes Care, and Johnson & Johnson Services, Inc. He has received grant/research support from Medtronic Inc., Abbott, and Valeritas.
H. Peter Chase, MD, has received grant/research support from Dexcom, Inc. and Medtronic, Inc.
Steven V. Edelman, MD, is a consultant for Abbott Laboratories, Bayer HealthCare Pharmaceuticals, LLC, Dexcom, Inc., and Johnson & Johnson Services, Inc. He is also a consultant for and on the speakers’ bureaus of Amylin Pharmaceuticals, Inc., Lilly, Novo Nordisk, and sanofi-aventis U.S. LLC.
Howard Wolpert, MD, is a consultant for Animas Corporation and has received grant/research support from Abbott Diabetes Care.
Publishing Staff Disclosures
Haymarket Medical Education (HME) staff have nothing to disclose with regard to commercial support.
Disclosure of Unlabeled Use
This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Albert Einstein College of Medicine of Yeshiva University, Lilly USA, LLC, and HME, do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine of Yeshiva University, Lilly USA, LLC, and HME. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
This program is sponsored by Albert Einstein College of Medicine of Yeshiva University
Produced by Haymarket Medical Education
If you have any questions relating to the accreditation of this activity, please contact Einstein CME at 718-920-6647.
This program supported by an educational grant from Lilly USA, LLC.
To obtain credit, a score of 70% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.